ACADIA PHARMACEUTICALS INC.
Revenue Breakdown
| Fiscal Year | NUPLAZID | DAYBUE |
|---|---|---|
| FY2023 | $549.2M | $177.2M |
| FY2024 | $609.4M | $348.4M |
| FY2025 | $680.1M | $391.4M |
Revenue Breakdown
| Fiscal Year | NUPLAZID | DAYBUE |
|---|---|---|
| FY2023 | $549.2M | $177.2M |
| FY2024 | $609.4M | $348.4M |
| FY2025 | $680.1M | $391.4M |